Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634036 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
A Phase 2 study of Asthma, sponsored by Fernando Holguin.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
- 2
- Study locations
NCT00634036: Completed Phase 2 study of Asthma, sponsored by Fernando Holguin.
NCT00634036 is a Phase 2 study of Asthma that has completed, run by Fernando Holguin. The registered enrollment target is 23 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634036, a Phase 2 study of Asthma, has completed, sponsored by Fernando Holguin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
- 2
- Study locations
Study Summary
Asthmatics who are significantly overweight tend to have more severe symptoms, more flare ups, and are more likely to have poorly-controlled asthma when compared to other asthmatics. Researchers believe this occurs because excess adipose tissue (fat) in the body can cause higher-than-normal levels of leptin and lower-than-normal levels of adiponectin in the blood. The researchers of this study are testing a medication called pioglitazone in overweight asthmatics because they believe it can help regulate leptin and adiponectin and that this may improve symptoms of asthma.
Conditions Studied
Interventions
- DRUG placebo
- DRUG pioglitazone
Study Locations (2)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Vermont
- University of Vermont - Colchester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634036
The ClinicalTrials.gov registry entry for NCT00634036 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The listed sponsor is Fernando Holguin, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00634036 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Vermont.
Frequently Asked Questions
What is clinical trial NCT00634036 about?
NCT00634036 is a clinical study titled "Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics". Asthmatics who are significantly overweight tend to have more severe symptoms, more flare ups, and are more likely to have poorly-controlled asthma when compared to other asthmatics. Researchers believe this occurs because excess adipose tissue (fat) in the body can cause higher-than-normal levels ...
What is the current status of trial NCT00634036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2009-10. Estimated completion is 2012-04.
What conditions does trial NCT00634036 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00634036?
The interventions under investigation include: placebo (DRUG), pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00634036?
This trial is sponsored by Fernando Holguin, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00634036 being conducted?
This trial has 2 study locations across Pennsylvania, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.